Showing results (101-110 of 319) with videos related to
Sort By:
Pageof 32
The Lancet. Oncology|January 29, 2022
A comprehensive framework for early-onset colorectal cancer researchCathy Eng, Alexandre A Jácome, Rajiv Agarwal, et al.Journal of Pain and Symptom Management|June 30, 2019
Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical TrialXin Shelley Wang, Qiuling Shi, Nishin A Bhadkamkar, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 14, 2007
Mode effects in the center for epidemiologic studies depression (CES-D) scale: personal digital assistant vs. paper and pencil administrationRichard J Swartz, Carl de Moor, Karon F Cook, et al.International Journal of Radiation Oncology, Biology, Physics|June 17, 2018
Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph NodesEmma B Holliday, Scott C Lester, W Scott Harmsen, et al.Lancet (London, England)|June 23, 2024
Colorectal cancerCathy Eng, Takayuki Yoshino, Erika Ruíz-García, et al.Cancer|April 7, 2006
Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancerPaulo M Hoff, Robert A Wolff, Henry Xiong, et al.Oncology|February 17, 2016
Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal CancerXin Shelley Wang, Qiuling Shi, Patrick M Dougherty, et al.Reviews in Endocrine & Metabolic Disorders|September 5, 2017
Management of pulmonary neuroendocrine tumorsRobert A Ramirez, Aman Chauhan, Juan Gimenez, et al.Ochsner Journal|September 27, 2021
A Peptide Meets a Radionuclide to Combat a Rare TumorKatharine E Thomas, J Philip Boudreaux, Ramcharan Thiagarajan, et al.Annals of Surgical Oncology|September 24, 2016
Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-upKeith Fournier, Safia Rafeeq, Melissa Taggart, et al.Pageof 32